Animal Therapeutics and Diagnostics Market to Reach $59.08 Bn, Globally, by 2030 at 5.9% CAGR: Allied Market Research

Increase in demand for animal-derived food items such as meat is the major factor driving the growth of the global animal therapeutics and diagnostics market.

PORTLAND, Ore., April 26, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Animal Therapeutics and Diagnostics Market by Product Type (Animal Diagnostics Products, Animal Therapeutics Products), by Animal Type (Companion Animals, Cattle, Pigs, Poultry, Sheep): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global animal therapeutics & diagnostics industry was estimated at $33.46 billion in 2020, and is anticipated to hit $59.08 billion by 2030, registering a CAGR of 5.9% from 2021 to 2030.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1949

Drivers, restraints, and opportunities-

Increase in demand for animal-derived food items such as meat is the major factor driving the growth of the global animal therapeutics and diagnostics market. Furthermore, surge in the incidence of chronic illnesses such as bovine spongiform encephalopathy as well as increase in knowledge of other zoonotic diseases boost the need for animal therapies and diagnostics among pet and cow owners. On the other hand, there is a vast knowledge gap regarding importance of therapeutic products in prevention of transmission of diseases to humans, which impedes the market growth to some extent. However, huge benefits of nanoparticles in the veterinary diagnostics and therapeutic products and combination of nanotechnology with molecular diagnostics can help improve the accuracy of treatment and diagnosis of animal diseases. This, in turn, is expected to create lucrative opportunities in the industry.

Covid-19 scenario-

• Lockdown measures across the world gave way to delayed production facilities. Manufacturing of animal diagnostic products and therapeutics was also hugely hampered, which impacted the global animal therapeutics & diagnostics market negatively, especially during the initial phase.
• However, as the global situation has started getting better, the market is projected to get back on track soon.

The animal therapeutics products segment to dominate by 2030-

By product type, the animal therapeutics products segment held the major share in 2020, garnering more than four-fifths of the global animal therapeutics and diagnostics market. The same segment is also projected to cite the fastest CAGR of 6.1% throughout the forecast period. Increase in concern over diseases that affect companion animals and the need to protect farm animals from epidemics drive the segment growth.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1949

The cattle segment to maintain the dominant share-

By animal type, the cattle segment contributed to the lion's share in 2020, holding nearly half of the global animal therapeutics and diagnostics market. Rise in the development of therapeutic products that can be used for the treatment of cattle diseases such as black quarter and foot-and-mouth diseases drives the growth of the segment. However, the companion animals segment is projected to manifest the fastest CAGR of 6.9% from 2021 to 2030. Increase in adoption rate of these animals augments the segment growth.

North America garnered the major share in 2020-

By region, North America dominated in 2020, garnering more than one-third of the global animal therapeutics and diagnostics market. There has been a rise in the awareness amongst consumers in this region about their source of food products, which has led to quality inspection of feeding products of livestock, thus propelling the market growth. The market across Asia-Pacific, however, is expected to cite the fastest CAGR of 8.1% throughout the forecast period.  Increase in urge to protect livestock from mass wipeouts due to epidemics, especially in countries such as India drives the market growth.

Key players in the industry-

• Eli Lilly and Company
• Zoetis Inc.
• Virbac S.A.
• Boehringer
• Ingelheim GmbH
• Bayer AG
• Sanofi S.A.
• Nutreco N.V.
• Merck and Co.
• Ceva Sante Animale

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Multivitamin Supplements Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Disposable EEG Electrode Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Fetal Valproate Syndrome Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Forensic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Fracture Product Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Hysterectomy Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Gene Sequencing Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

India Disposable Syringes Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Medical Cannabis Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Veterinary Teleradiology Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg